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A number of infected individuals develop neuropathological disorders, such as AIDS dementia complex (ADC), as a
consequence of HIV/AIDS. The biological features governing HIV entry and tropism in different brain cell types remain
unclear, as do the genetics of the virus regulating these events and the neuropathogenic processes within the brain tissues.
HIV-1 was isolated from the right and left parietal, occipital, and frontal lobes of the brain cortex of three HIV-1-infected
patients: two with ADC and one without. The viral strains were studied from the innate tissues and various primary cell
cultures. The kinetics and tropism of viral strains from different brain regions showed clear differences on various primary
cell types (monocytes, monocyte-derived macrophages, and T cells), which could discriminate between biological behavior
of HIV-1 strains from patients with and without ADC. The variable effect of different donor cells on tropism was also clearly
evident. The majority (with a few exceptions) of isolates from different brain regions of all three patients used CCR5 as
coreceptor for entry. The consistent CCR5 use, macrophage tropism, and non-syncytium-inducing phenotype were the main
characteristics of the brain-derived HIV-1 strains from all three patients. Importantly, viral strains derived directly from innate
brain tissue of the patient without ADC showed some differences from the cultured variants of the same patient, whereas
those from brain tissue of the patients with ADC were more similar to the culture-adapted strains. This suggests that the
emergence of primary cell type-adapted isolates during ADC may play a crucial role in the development and progression of
the neuropathology associated with ADC. The different genotypes residing in different areas of brain combined with their
differential tropism and coreceptor use suggest that neurotropic variants exist that may be governing the neurological
manifestation of HIV disease in infected patients. © 2001 Academic Press
















In addition to targeting the human immune system,
human immunodeficiency virus type 1 (HIV-1) has been
recognized for its ability to directly target the peripheral
and central nervous (CNS) systems (Price, 1988) during
the early stages of infection (Resnick et al., 1988; Davis et
al., 1992). As a consequence of the invasion of the CNS,
various neuropathological disorders may occur, with the
most prominent being AIDS dementia complex (ADC).
ADC occurs in about 20–50% of HIV-1-infected individu-
als (Atwood et al., 1993; McArthur et al., 1993) and is
characterized by a range of cognitive, motor, and behav-
ioral changes that vary in severity as the disease
progresses (Michaels et al., 1988; Price et al., 1988).
Apart from CD41 T-lymphocytes, which are major tar-
ets for infection with HIV, cells of the mononuclear
hagocyte system, including macrophages, microglia,
1 To whom correspondence and reprint requests should be ad-
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509nd multinucleated giant cells of the brain, also play a
ritical role, both as host cells and as reservoirs, for HIV
n vivo. HIV proviral sequences and proteins have been
hown to be present in the brain tissue of infected
atients with or without neuropathological symptoms
Shaw et al., 1985). In the majority of cases, microglia,
hich are the specialized resident macrophages in the
rain tissue, are productively infected. However, in pa-
ients with severe HIV-related dementia, neuropathy, or
oth, astrocytes and neurons may also become infected
ith HIV-1 (Wiley et al., 1986). Although a number of
ypotheses have been proposed, the cause of the neu-
opathogenesis remains unclear, but it appears that the
nfection of microglial cells is an essential component of
he development of ADC.
The env V3 region has been reported to be a primary
determinant of macrophage tropism and cytopathicity
(Chesebro et al., 1992; De Jong et al., 1992; Fouchier et
al., 1992; Hwang et al., 1991; Korber et al., 1994; Shioda et
al., 1994). Single amino acid changes within the V3 re-
gion have been shown to alter the viral tropism and entry
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510 SMIT ET AL.(McKnight et al., 1995). So far, no definitive molecular and
biological mechanisms are known for the neurotropism
of HIV-1 in relation to amino acid changes in the HIV-1
envelope gene. However, a partial association between
AIDS dementia and sequences in the V3 region has been
described (Chang et al., 1998; Donaldson et al., 1994;
Keys et al., 1993; Korber et al., 1994; Power et al., 1994).
There is evidence suggesting that genetic heteroge-
neity in HIV may play a role in the infection of microglial
cells. This evidence is based on the fact that although
HIV can be isolated from the cerebrospinal fluid of more
than 50% of individuals early in the course of disease,
infection of the CNS occurs in only about 20% of infected
individuals, despite the preponderance of macrophage-
tropic strains, most of which can replicate in microglia
(Strizki et al., 1996). Furthermore, it has been shown that
viruses infecting the CNS of HIV-infected patients differ
from HIV strains prevalent in the systemic circulation (Di
Stefano et al., 1996; Epstein et al., 1991; Korber et al.,
1994; Wong et al., 1997), and by comparing viruses from
blood and different regions of the brain of the same
patient, the segregated evolution of viral strains in differ-
ent brain regions of the same patient was proposed
(Saksena et al., 1998; Chang et al., 1998).
It remains unknown as to how the regional variation in
the env gene of HIV-1 strains, derived from different
areas of adult brain cortex from patients with and without
ADC, may influence their biological/pathological proper-
ties on primary cell types, such as peripheral blood
mononuclear cells (PBMCs), monocytes, and monocyte-
derived macrophages (MDMs). By comparing the molec-
ular changes in HIV-1 strains in vivo with brain-derived
isolates passaged into related primary cell types, such
as monocytes and MDMs, we may be able to extrapolate
valuable information regarding the neurotropism of HIV-1
in brain cell types.
With this in view, we carried out a detailed compara-
tive biological and molecular analyses in vivo and in vitro
of the HIV-1 viral isolates derived from three patients (two
with ADC and one without ADC) from different regions of
the adult brain cortex [left and right parietal (LP and RP),
frontal (LF and RF), and occipital lobes (LO and RO)] on
primary monocytes, MDMs, and T-lymphocytes and de-
termined their modes of entry. Overall, our molecular and
biological analyses suggest that differences in tropism of
viral isolates on different primary cell types can discrim-
inate between patients with and without ADC. Further,
these data show that neurotropic variants exist that may
play a role in neuropathogenesis.
RESULTS
Histopathology
Patient ND (nondemented). Examination at autopsy
showed normal brain cerebellum, brain stem, and me-
ninges. Histopathological examination of the brain sec-tions showed subependymal, periventricular changes
that consisted of cells with abundant eosinophilic cyto-
plasm, some of which exhibited characteristic “owl eye”
nuclei of cytomegalovirus (CMV) infection (data not
shown). The immunoperoxidase staining for CMV was
positive: several infected cell types were seen, which
included ependymal cells, astrocytes, endothelial cells,
and microglia/macrophages. Other microglial nodules
were seen in the underlying parenchyma, and astrocyto-
sis was evident in many regions (Figs. 1a–1c).
Patient LD (late-stage dementia). Histopathological ex-
amination of various regions of the brain of patient LD
showed mild diffuse leukoencephalopathy with subtle
variations in different regions of the brain. The right
frontal (RF) (Fig. 1d), left frontal (LF), midbrain (Fig. 1e),
and right parietal (RP) (Fig. 1f) regions showed easily
identifiable perivascular multinucleated giant cells. By
contrast, the LP, right and left occipital (RO and LO), and
right and left temporal regions (data not shown) tended
to show more prominent perivascular mononuclear mac-
rophages with occasional giant cells. Microgliosis was
more frequently observed in basal ganglia, midbrain,
pons, medulla, and cerebellar hemisphere. A mild de-
gree of astrocytosis was present in many parts of the
brain, along with mild patchy leptomeningitis. The forma-
tion of multinucleated giant cells, microglial nodules, and
lymphohistiocytic infiltration are characteristic of ADC
(Chesebro et al., 1992).
Patient ED (early-stage dementia). Examination of the
brain specimens obtained at autopsy showed several
HIV-specific neurohistological features, including
perivascular infiltration with clusters of multinucleated
giant cells, prominent astrocytosis, microglial nodules,
necrosis in areas of white matter, and perivascular infil-
tration of giant cells in gray matter of LF and RF, parietal,
and occipital lobes (Figs. 1g–1i). Varying degrees of
multinucleated giant cells and astrocytosis could also be
seen in right caudate, thalamus, hippocampus, medulla,
pons, midbrain, and cerebellum (data not shown). Over-
all, the degree of brain cell damage was least pro-
nounced in gray matter of occipital lobes, corpus collo-
sum, and mamillary body.
Tropism of HIV-1 strains from various cortical regions
on primary cell types
A variable tropism was seen on monocytes, MDMs,
and T-lymphocytes for viral strains derived from different
brain regions for each of the patients (Figs. 2a–2c). The
line graphs in Figs. 2a–2c show the p24 antigen dynam-
ics on monocytes, MDMs, and T cells prepared from the
blood of donor B (used for all three patients). Despite
variation in tropism of HIV-1 on different primary cell
types from donor B, there is evidence showing that iso-
lates from patient ND (nondementia) harbor the propen-
sity to grow actively and near equivocally on T-lympho-
nd per
511NEUROTROPISM OF HIV-1cytes. The same isolates grew more moderately on
monocytes and MDMs with a low and gradual decline in
the p24 antigen level from days 14–21 postinfection. By
contrast, viral isolates from patients with dementia (pa-
tients LD and ED) grew well on macrophages, with a
steady increase and peak in the p24 antigen level by
days 18–21 postinfection. The viral isolates from the RF,
LO, LP, and RP regions of patient LD and the LO, LP, and
RP regions of patient ED grew well on monocytes within
the first 14 days and then tended to show a decline in the
p24 antigen level by days 18–21 postinfection. The LF
and RO regions of patient LD grew quite poorly and to a
low level (,120 pg/ml) by day 21. Similarly, viral isolates
from the LF, RF, and RO regions of patient ED grew quite
slowly for the first 14 days and then showed a steady
increase in the p24 antigen level until termination of the
cultures at day 21.
By contrast to the strains derived from patient ND, all
the strains from patient LD (except RP) and patient ED
(except RF and RP) grew poorly on T-lymphocytes. Col-
umns A–C of Table 1 represent PBMCs from three dis-
tinct HIV-seronegative donors used for the preparation of
monocytes, MDMs, and T-lymphocytes by elutriation.
FIG. 1. Histopathology of different brain regions of patients ND (a–c)
was seen in the LP, RO, and cerebellum of patient ND, respectively. Per
and perivascular clusters of mononuclear macrophages (f) were seen
cluster of mononuclear giant cells (g), astrocytosis and giant cells (h), a
LF, and RP regions of patient ED, respectively.The relative p24 antigen levels are indicated for day 21
postinfection. For patient ND, all isolates infected MDMsand all except the RF region infected T-lymphocytes
consistently. However, all isolates were able to infect
monocytes derived from donor B, but only the isolates
derived from the LP and RO regions were able to infect
the monocytes derived from donor A. Similarly, for pa-
tients LD and ED, most isolates were able to consistently
infect MDM from two different donors (Table 1). However,
only some of the isolates could infect T-lymphocytes
from either or both donors, as is the case for isolates
from patient ED infecting monocytes. For patient LD, only
two isolates could infect monocytes from donor A,
whereas five of the six isolates could infect cells from
donor B. These results suggest a near-consistent tro-
pism for infection of primary MDMs, but one that is more
varied for T-lymphocytes and significantly variable in the
case of monocytes.
NSI/SI viral phenotype
Culture supernatants derived by coculture of different
brain regions from patients ND, LD, and ED were used to
infect the MT-2 cell line. Without exception, the HIV-1
strains from all of the brain regions of all three patients
–f), and ED (g–i). Astrocytosis (a) and (b) and microglial nodulation (c)
ar multinucleated giant cells (d), giant cells with mononuclear cells (e),
RF, midbrain, and LP regions of patient LD, respectively. Perivascular
ivascular infiltration of mononuclear giant cells (i) were seen in the RF,, LD (d
ivascul
in therevealed a non-syncytium-inducing (NSI) phenotype,
















512 SMIT ET AL.(35-amino acid region of env gp120) charge (between 11
and 13) as depicted in Figs. 3a–3c.
oreceptor use of brain-derived HIV-1 isolates
The culture of expanded brain-derived viral isolates on
uman osteosarcoma (HOS) cells expressing the CD4
ntigen and one or another of the specific chemokine
eceptors showed that CCR1, CCR2b, CCR3, and CXCR4
ere not used by any of the isolates. Most isolates
redominantly used CCR5 (Table 1), with rare use of BOB
nd BONZO by some of the HIV-1 strains from patients
D and ED. In addition, viral strains from patients LD
regions LF and LP) and most of ED did not use CCR5 or
ny of the other coreceptors, suggesting that other un-
nown coreceptors may be used. The CCR5 use was
onsistent with the predominantly macrophage-tropic
ature of the brain-derived HIV-1 strains. Despite several
FIG. 2. p24 antigen kinetics for patients ND, LD, and ED on primary
p24 Antigen Assay. a1, a2, and a3 represent the kinetics on T-lymphocyte
the kinetics on monocytes for patients ND, LD, and ED, respectively. T
MDMs, and monocytes in a1, b1, and c1, respectively.ttempts at defining coreceptor use for all isolates from
atient ED, we were still unable to detect any p24 anti-gen in the supernatant or to amplify any proviral DNA by
PCR from the infected HOS cells.
V3 region sequences of output HIV-1 strains from
different primary cell types
Using PCR, we successfully amplified 666 bp in the
C2-to-V5 regions of the env gene from both input (brain
tissue) and output viruses (infected PBMCs, monocytes,
MDMs, and T cells). The PCR fragments were se-
quenced, and the 35-amino acid sequences encompass-
ing the V3 loop region were compared.
The net V3 loop charges and hydrophilicity values
were determined (Figs. 3a–3c) using DNA ID 1.8. Overall,
there was a marked intrapatient similarity among the V3
region sequences, net V3 loop charge, and hydrophilicity
values derived from infected monocytes, MDMs, and
T-lymphocytes for each of the patients (Figs. 3a–3c). It
es as determined on days 7, 14, and 21 postinfection using the HIV-1
2, and b3 represent the kinetics on MDMs; and c1, c2, and c3 represent
tics for prototype strains HIV-BaL and -pNL4-3 are shown on T cells,cell typ
s; b1, bhas been shown that NSI isolates have lower positively





















513NEUROTROPISM OF HIV-1SI isolates (63.6 versus 65.6, Fouchier et al., 1992).
Interestingly, there was a higher variation in the net V3
loop charge in brain tissue-derived sequences from pa-
tient ND (11 to 13) (Fig. 3a), whereas the net V3 loop
charge was more homogeneous in brain tissue-derived
sequences of patient LD (all 12) (Fig. 3b). We could not
determine the HIV-1 sequences in innate brain tissue
from patient ED, but the viral sequences determined from
cultured PBMCs consistently revealed a lower net V3
loop charge (11 to 13), characteristic of the NSI pheno-
type (Fig. 3c).
Critical observation of the V3 region sequences from
brain tissue and infected PBMCs, monocytes, MDMs,
and T-lymphocytes revealed a number of specific
changes at particular amino acid locations in each of the
patients. A consensus motif S/GXXXGPGXXXXXXXD was
clearly observed in all of our sequences from all three
patients depicted in the shaded areas of Figs. 3a–3c and
5. The exceptions were the clones NDROmA (Figs. 3a
and 5) and NDROc.3 (Fig. 3a), which have an S3 C and
S3 R transition, respectively, at amino acid 30 of the env
V3 loop regions. For patients ND and ED, the motif read
consistently as SXXXGPGRXXXXXXXD. For patient LD,
here was a near-consistent S 3 G transition and a
onsistent R3 S at amino acids 30 and 37, respectively.
he exceptions were LDLO, LDROc.22, LDROc.22,
DRPT.B, LDRPm.A, LDRPMon.A, and LDRPMon.B,
T
Tropism of Brain-Derived Isolates from Patients ND, LD, and
and HOS-CD41 Cells Transfected
Note. Patient NDC, no dementia; Patient LDC, late dementia;
from whom monocytes, MDMs, and T cells were prepared; NSI
Estimated p24 antigen levels at day 21 postinfection are indicate
200–400 ng/ml; 111, 400–600 ng/ml; 1111, .600 ng/ml; 2,hich had an S at position 30. The tetrapeptide motifs
emained consistent for patients ED and LD with GPGRnd GPGS tetrapeptides, respectively. The brain tissue-,
DMs-, and monocyte-derived sequences for patient
D revealed a consistent GPGR motif, which was also
ominant in the PBMC clone sequences, although GLGR
nd GSGR occurred in two of the clones (Figs. 3a–3c
nd 5).
There were very few changes that related to a specific
ell type or to the particular donor cells used. A summary
f the molecular changes is shown in Table 2. Interest-
ngly, for both patients ND and LD, specific changes that
ppear to relate to the donor cells used, in particular in
elation to the MDM-derived strains, were noted. Some
f these are indicated in Table 2 (viz., changes at amino
acids 39, 78, 81, and 87 for patient ND and 13, 81, and 87
for patient LD; Figs. 3a and 3c and Table 2). In addition,
there are changes at positions 4 (N 3 S), 13 (N 3 S or
K), and 28 (R3 G) for patient ND and positions 84 (F3
L) and 87 (S 3 F) for patient LD, which may also be
donor cell specific. For patient ED, the monocyte-derived
sequences seem to contain a more varied quasispecies
compared with the strains derived from the PBMC
clones, T cells, and MDM cultures, suggesting a more
tissue-specific variation and/or adaptation.
Phylogenetic analyses
The phylogenetic analysis was conducted using the
Primary Monocytes, MDMs, and T-Lymphocytes, MT-2 Cells,
ne of the Chemokine Receptors
EDC, early dementia; A*, B*, and C*, the three different donors
yncytium-inducing; SI, syncytium-inducing; ND, not determined.





, non-sneighbor joining algorithm with 100 bootstrap replica-
tions. A total of 276 bp encompassing the V3 loop region
en sub
514 SMIT ET AL.of the env gp120 and common to all sequences derived
from output viruses from monocytes, T cells, MDMs, and
clones from PBMC cultures, as well as sequences from
the brain tissue, were compared simultaneously from all
three patients.
There was independent clustering of the brain tissue-
derived sequences for patient ND, as seen in shaded
area I (Fig. 4a). There was little clustering according to
either the brain regions or primary cell types infected in
the remainder of the sequences, except in shaded areas
II and III (Fig. 4a). Area II represents a clustering of
MDM-derived sequences, in particular those from donor
A cells, suggesting a donor influence on the viral quasi-
species selected. Area III represents a clustering of
sequences, predominantly from the RP region of patient
FIG. 3. Amino acid alignment of input viral sequences (derived from i
monocytes, MDMs, and T cells for patients ND (a), LD (b), and ED (c
determined. The net charge and hydrophilicity values on the right o
represented within the boxed area and with bold text for the prototype
consensus motif (S/GXXXGPGXXXXXXXD). These sequences have be
AY010804-851 (Pat #LD); and AY010759-803 (Pat #ED).ND, as well as clone 3 from the RO region (NDROc.3).
There was significant intermingling of sequences de-rived from both tissue and various primary cell types in
patient LD (Fig. 4b). In addition, the sequences derived from
the brain tissue from four of the six regions are clustered in
the center of the tree off the same minor branch (area IV).
LDLO lies on a separate major branch, whereas LDRO
branches off on one of the later minor branches. There is
regional clustering as shown in shaded areas V and VI, for
the RP and LP regions, respectively.
There were no sequences derived directly from the
brain tissue of patient ED, as only supernatants from
tissue-derived viral isolates were available. We observed
clustering of monocyte-derived sequences (Fig. 4c,
shaded area VII) and some segregation of cloned se-
quences from the RP region and LO regions. There was,
however, little evidence of tissue-specific clustering.
rain tissue) and output viral sequences derived from cultured PBMCs,
ectively. In the case of ED, only sequences from cultured cells were
ure have been calculated using DNA ID 1.8 for the V3 loop region
subtype B strain SF2. The shaded area represents the location of the
mitted under the GenBank Accession Nos. AY010852-895 (Pat #ND);nnate b
), resp
f the fig
HIV-1In patient ND, the clustering of the tissue-derived se-
quences (Fig. 4a) on major branches of the tree suggests
—Cont
515NEUROTROPISM OF HIV-1that these sequences are significantly different from
those derived from culture on primary cell types. Be-
cause we have sequenced only the major populations
from the different brain regions of patient ND, this may
suggest the selection of minor variants on primary cell
types used in our studies. It can clearly be seen (Fig. 4a)
that there was regional variation in innate brain-derived
strains, and the selection in vitro may have occurred only
from a few regions, because the output viral variants
derived from different primary cell types are related. By
comparison, the intermingling of the innate tissue-de-
rived sequences with those of the culture-derived se-
quences in patient LD (Fig. 4b) suggests that the virus
present in the brain tissue of this patient has already
undergone significant evolution and adaptation to
growth on particular cell types. This evolution may be a
FIG. 3requirement for the progression toward ADC.
Furthermore, the clustering within patient ND (Fig. 4a,areas II and III) is more cell type specific than region
specific, whereas that for patient LD (regions V and VI) is
more region specific than cell type specific. These data
suggest that the virus in ADC patients may undergo
independent evolution within the different brain regions.
This independent evolution may be less advanced in the
nondemented patient (ND).
Overall genetic and phylogenetic examinations of the
V3 region sequences from innate tissues and cultured
primary cells did not reveal any consistent pattern that
could clearly demarcate between viral strains from pa-
tients with and without ADC.
Coherence between macrophage-tropism and CCR5
use
inuedCoreceptor utilization was studied for all of the viral
strains derived from different regions of the brain of all
—Cont
516 SMIT ET AL.three patients. In the case of patient ED, none of the
HIV-1 isolates used any of the coreceptors studied on
HOS-transfected cell lines, including CCR5 (Table 1). In
the case of patient ND, all strains used CCR5, but in
patient LD, viral strains from the LF and LP regions failed
to use CCR5.
Sequences from the MDMs and HOS cells, infected
with the same viral supernatants of patients ND and LD,
were compared to determine the genetic compatibility
between output viral strains, to delineate whether mac-
rophage tropism is determined by CCR5 use. Interest-
ingly, there was a high concordance between the strains
from the same patient (Fig. 5). The majority of amino acid
changes in the R5 strains were also present in the MDM
strains, although some additional changes were specific
to the MDM-derived strains. The molecular changes that
were commonly conserved between viruses derived
from MDM and HOS-CCR51 cells in both patients (ND
FIG. 3and LD) were seen at positions 17, 41, 44, and 60 (Fig. 5).
The conservation of these residues may have a func-tional significance; therefore we hypothesize that similar
changes in the env gene may govern both macrophage
tropism and CCR5-dependent entry.
DISCUSSION
The mechanisms of entry of HIV-1 into the CNS, the
neurotropism of different HIV-1 strains on various brain
cell types, and the mechanisms responsible for the de-
velopment and progression of ADC remain poorly under-
stood. The biological features that govern viral entry and
tropism in different cell types remain unclear, as do the
genetics of the virus regulating these events and the
neuropathogenic processes within the brain tissues.
In this study, we investigated whether the viral strains
derived from different regions of adult brain cortex of
HIV-1-infected patients with and without ADC differ in
their molecular edifice, replication, mode of entry via
inuedcoreceptor use, and tropism on different primary cell
types. A detailed biological and molecular analysis of
nylalan
517NEUROTROPISM OF HIV-1differences between HIV-1 strains derived from various
brain regions has provided insight into their evolution
and has confirmed the presence of CCR5, NSI, and
macrophage-tropic variants within the brain isolates,
which may have biological significance in the neurolog-
ical manifestation of HIV disease.
The kinetics and tropism of the viral strains derived
from different regions of the brain cortex of the three
patients in our study, on primary cell types, revealed a
distinction in the biological behavior of HIV-1 strains from
patients with and without ADC. Although most variants
from all three patients grew on MDMs and monocytes,
only those from the patient without ADC (patient ND)
were able to consistently replicate and infect T-lympho-
T
Detailed Amino Acid Substitutions in
Note. Abbreviations for amino acids are a
D (aspartic acid), E (glutamic acid), Q (glut
(leucine), M (methionine), K (lysine), F (phe
(tyrosine), and V (valine).cytes. Also, our data clearly show that the viral strains
from patients ED and LD revealed more variation intropism on all three primary cell types, whereas the
isolates from patient ND revealed more homogeneous
tropism patterns on three primary cell types, suggesting
a biological difference between HIV-1 strains from de-
mented versus nondemented patients.
Our results suggest that CCR3 is not utilized by any of
the brain-derived isolates studied. This is in agreement
with the finding of Shieh et al. (1998), who found no
compelling evidence for CCR3 predominance among
CNS strains on adult brain-derived microglial cells. Fur-
thermore, our results do not support the use of CXCR4 as
a coreceptor by these brain-derived isolates as shown
by the lack of p24 antigen expression and PCR amplifi-
cation of the env gene from HOS-CD4 cells transfected
uences for Patients ND, LD, and ED
s: A (alanine), R (arginine), N (asparagine),
, G (glycine), H (histidine), I (isoleucine), L
ine), P (proline), S (serine), T (threonine), YABLE 2
the Seq
s follow
amine)with CXCR4. Mitogens and interleukin-2 (IL-2) are known
to up-regulate the expression of CXCR4, but not CCR5,
logene
HIV-1 s
518 SMIT ET AL.on PMBCs (Bleul et al., 1997). Thus despite the potential
for the selection of CXCR4 using strains during viral
expansion on the mitogen- and IL-2-stimulated donor
PBMCs, there is no evidence for CXCR4 use, even on
T-lymphocytes, by strains of patient ND. This suggests
that infection of the T-lymphocytes is predominantly me-
diated through CCR5. There may also be a selective
amplification of SI viruses in PBMC cultures (Donaldson
et al., 1994), but we were only able to detect viruses of
the NSI phenotype, characterized by a lower net V3 loop
charge.
FIG. 4. Neighbor joining phylogenetic tree based on a 276-bp region
sequences derived for patients ND (a), LD (b), and ED (c), respective
monocytes, MDMs, and T cells. In the case of patient ED (c), the phy
primary cell types only. The sequence for SF2, a subtype B prototypeDespite the fact that the criteria used for defining the
variants biologically are limiting and not absolute, ourdata are conclusive in showing that the brain-derived
isolates are all of the NSI phenotype, macrophage tropic,
and predominantly use CCR5 as coreceptor or, in some
cases, an as yet unidentified coreceptor.
Our data clearly show the differences in tropism of
brain-derived HIV-1 isolates on different primary cell
types derived from different donors. This could be related
to contributing host factors, such as the relative expres-
sion of chemokine receptors and cytokines that affect
viral entry, transmission, and spread. Because the viral
infectivity varied on monocytes, MDMs, and T cells de-
env encompassing the V3 loop region, showing the relationship of the
innate brain tissue and variants derived from coculture on PBMCs,
tic constructs were done using the sequences derived from cultured
train, was derived from the Los Alamos database.of the
ly, fromrived from different donors (A, B, and C), there must be
host (donor) factors contributing to the susceptibility of
—Cont
519NEUROTROPISM OF HIV-1different primary cell types to infection by these brain-
derived isolates that may as a consequence also con-
tribute in part to the neurological manifestations of HIV-1.
Levels of CCR5 are reported to correlate with the
infectability of cells by M-tropic HIV (Wu et al., 1997), and
thus it may also be necessary to determine the relative
expression of CCR5 on cells of the brain parenchyma
and within different regions of the brain. However, the
level of expression may be transient and driven by the
other host factors.
The CCR5 coreceptor use, macrophage tropism, and
NSI phenotype that characterized the majority of brain-
derived HIV-1 strains from all three patients give empha-
FIG. 4sis to the importance of macrophage-tropic strains in the
neurotropism of HIV-1. It has previously been shown byWatkins et al. (1990) that macrophage-adapted labora-
tory HIV-1 strains, but not T-lymphocyte-adapted HIV-1
strains or HIV-2 isolates, infect primary cultures of hu-
man adult brain containing CNS resident macrophages,
microglial cells, and astrocytes. This indicates that there
is a selective requirement for macrophage-tropic viral
strains to sanction infection of cells of the brain paren-
chyma.
The neurotropic variants of HIV-1 appear to evolve
independently within the brain tissue. The emergence of
monocyte/macrophage-adapted isolates during ADC,
which is in contrast to the development of SI CXCR4
using T-tropic variants commonly seen in the systemic
inuedcirculation with the progression to AIDS (Connor and Ho,




520 SMIT ET AL.development and progression of the neuropathology as-
sociated with ADC.
This variation in mode of viral entry via coreceptor use
and loss of T-lymphocyte tropism with progression of
ADC may be an indirect indication of chemokine recep-
tor-mediated evolution of microglia and/or macrophage-
tropic strains of HIV-1. Some viruses have an intrinsic
capacity to use multiple receptors, such as the herpes
virus (Tufaro, 1997), whereas others may change their
capacity to bind receptors or coreceptors by mutational
changes in the binding domains of the envelope proteins
(Schneider-Schaulies, 2000). Both mechanisms are evi-
dent during HIV infection, enabling the spread of the
FIG. 4virus to different organs and cell types. In addition, virus–
receptor interactions may induce signal transduction
h
devents resulting in cytokine secretion, apoptosis, im-
mune stimulation, or immune suppression. This in turn
could lead to the neurological impairment seen during
the HIV clinical course. The finding that the majority of
brain-derived isolates are predominantly R5, macro-
phage-tropic variants may provide a plausible explana-
tion for the low or absence of infection of astrocytes and
neurons in the CNS, which predominantly express CCR3
and/or CXCR4 (Gabuzda et al., 1998; Lavi et al., 1997;
Patton et al., 1996; Vallat et al., 1998; Zheng et al., 1999).
In this context, it is also important to mention that the
nfection of microglia can occur via receptors other than
CR5 or CCR3 (Shieh et al., 1998; Strizki et al., 1996). It
inuedas recently been demonstrated using foot-and-mouth
isease virus that cell surface molecules acting as virus
with bo
).
521NEUROTROPISM OF HIV-1receptors may exert important selective pressure on
RNA viral quasispecies to select for alternative receptors
for attachment and entry into cells, and as a conse-
quence multiple coreceptors can be used by the virus to
enter the same cell type (Baranowski et al., 2000). Thus
it is plausible to hypothesize that the absence of use of
CCR5 and any of the major coreceptors by some of the
brain-derived strains suggests the entry to be mediated
by some unknown receptor molecule, which is also in
agreement with the data by Ghorpade et al. (1998). Be-
cause we analyzed authentic brain-derived strains, our
results demonstrate this phenomenon of coreceptor use
variation in a true sense.
Similar to our study, the selection of HIV genotypes by
cultivation in various primary cell types was shown by
von Briesen et al. (1999). However, our analyses uniquely
demonstrate the possible contribution of molecular
changes in brain-derived variants to the differences in
viral entry and tropism in a particular cell type. Similarly,
such changes can also take place when different donors
are used, as evident in our coculture experiments, and
highlights the need to assess and characterize the bio-
logical nature (chemokine and cytokine expression) and
genetic nature (presence of certain polymorphisms, par-
ticularly in the CCR5 gene) of the donor cells used for in
vitro analysis.
Although we observed tropism differences between
the viral strains from demented and nondemented pa-
tients, we failed to locate a consistent pattern of molec-
FIG. 5. Multiple amino acid alignment showing comparison of output
and LD. The V3 loop region is represented within the boxed area and
represents the location of the consensus motif (S/GXXXGPGXXXXXXXDular changes that can differentiate between these two
groups. We observed greater compatibility between theselection of input viral variants from innate brain tissues
and output variants from PBMC and T cells. The molec-
ular differences in comparison to the input viruses were
more apparent in the monocyte- and MDM-derived se-
quences, which again emphasizes their relevance in
neurotropism.
The env gp120 crystal structure has revealed that the
V3 loop resides proximal to the chemokine receptor-
binding site, masking the more conserved elements of
the env gp120 and thereby facilitating the presentation of
potentially visible epitopes to the immune system (Wyatt
et al., 1998). Thus mutations in the V3 region of HIV-1
strains may have immense relevance in viral tropism
both in vivo and in vitro and may also form the basis for
neurotropism.
According to Xaio et al. (1998), a consensus motif,
S/GXXXGPGXXXXXXXE/D, within the env V3 region ap-
pears to be involved in CCR5 coreceptor use. This motif
was prevalent in most of our sequences derived from
brain tissue and from the various primary cell types
infected with brain isolates, including those from infected
T-cell cocultures.
Although it is known that at least some of the genetic
determinants of viral tropism and entry lie in the enve-
lope gene (Chesebro et al., 1992; Fouchier et al., 1992), it
remains unclear how the molecular changes within the
envelope gene of different strains may govern their entry
and tropism into the different brain cell types. Because
no studies to date have shown molecular changes in the
ces derived from MDM- and HOS-CCR5-infected cells for patients ND
ld text for the prototype HIV-1 subtype B strain SF2. The shaded areasequenenv gene of infecting HIV-1 strains to harbor changes





































































522 SMIT ET AL.tients, it is likely that single amino acid changes may be
more crucial in neuropathogenesis. Data on several
other viruses, such as rhabdoviruses, flaviviruses, retro-
viruses, and alphaviruses (Dietzschold et al., 1993;
awano et al., 1993; Szurek et al., 1990; Tucker et al.,
993), suggest that the major determinants of virulence
n the development of neurological disease are often
ingle amino acid changes in the surface proteins.
Our study has focused on the V3 env regions because
f its significant role in chemokine receptor utilization,
ell tropism, cytopathicity, and infectivity. However, it will
e necessary to extend our investigation to the env
p160 gene as a whole as well as to other regulatory/
ccessory genes to determine whether there are other
olecular changes affecting the viral phenotypes within
he brain that may better serve to discriminate between
atients with and without ADC.
Although our investigation is extensive, the study
roup consists of only three patients, but in time we hope
o extend our studies to include additional patients with
r without ADC to determine whether there are any
dentifiable molecular trends that may well serve to dis-
riminate between these two patient sets.
Our data substantiate and highlight the importance of
SI phenotypes of the brain-derived HIV-1 strains and
mply that T-lymphocytes may be insignificant in directly
arrying or transmitting HIV within the CNS or across the
lood-brain barrier. This also corroborates why mono-
ytes and macrophages, which both express CCR5, are
he likely vessels for transmission.
We hypothesize that at the early stage of HIV-1 infec-
ion, both dual-tropic and macrophage-tropic strains may
nfect the CNS. Due to selective pressures within the
rain parenchyma, however, macrophage-tropic variants
re selected out and become the prevailing phenotype of
he quasispecies within the brain parenchyma. The host
nvironment pressures driving the establishment of the
acrophage-tropic strains may be related to the receptor
olecules on the surface of the different cell types
resent within the brain (resident macrophages, micro-
lial cells, and astrocytes), as well as neuropathological
hanges occurring as a result of progression of the ADC.
In addition, we propose that although in most cases it
ay be peremptory for HIV-1 to use a specific receptor
or entry, in particular with regard to the primary receptor,
D4, it may be only discretionary as to which coreceptor




Viral isolates derived from different regions of the adult
rain from three HIV-1-infected patients, two with and
ne without ADC, were studied. Tissue samples from the
rontal, parietal, and occipital regions of the left and right
s
rortical hemispheres of the brain were collected at post
ortem from the three patients and stored at 270°C.
Patient ND. Patient ND was a 48-year-old man with
category IVC AIDS accompanied with HIV wasting dis-
ease. The patient received AZT and ddI between 1990
and 1994 and discontinued the treatment due to drug
intolerence. Subsequently, the patient died in 1995 of
AIDS and CMV-related neurological disorder. Postmor-
tem examination revealed that he had CMV retinitis,
CMV ventriculitis, and encephalitis, but there were no
features to suggest HIV encephalitis.
Patient LD. Patient LD was a woman diagnosed with
HIV-1 infection in 1988, which she acquired heterosexu-
ally from her partner. Patient LD received monotherapy
with AZT between 1991 and 1993. Her AIDS-defining
illness was characterized by oral and esophageal can-
didiasis and the development of neurological disease
accompanied by unsteady gait, falls, headaches, partial
seizures, and dysphasia in 1994. For a short period in
1994, she received monotherapy with ddI when her CD41
T-cell count was 100 cells/ml blood. In late 1994, with
worsening neurological disease, patient LD died at age
44 with progressive ADC and a CD41 T-cell count of 40
cells/ml blood.
Patient ED. Patient ED was a 23-year-old homosexual
an who developed ADC and died of AIDS within 40
eeks of presenting with primary HIV infection (Holland
t al., 1997). He received both AZT and ddI but discon-
inued ddI because of paresthesia. By week 33, the
atient had detached affect and poor short-term memory.
e was readmitted to the hospital at week 36 with
treptococcus pneumoniae infection and dementia. At
ost mortem, he was shown to have HIV encephalitis.
istology
Tissue samples were collected at post mortem from
arious parts of the brain of each of the patients, paraffin
mbedded, and fixed in 20% formalin. Sections were cut
mm thick, stained with hematoxylin and eosin, and
xamined under a light microscope.
xpansion of brain-derived HIV-1 isolates
Tissue samples from the frontal, parietal, and occipital
egions of the left and right cortical hemispheres of the
rain were collected at post mortem from patients ND,
D, and ED and stored at 270°C. Frozen tissue samples
60.3 cm3) from each of the regions of each patient were
isrupted under liquid nitrogen. The tissue fragments
ere then placed in culture on HIV-negative donor
BMCs that had previously been stimulated with phyto-
emagglutinin (PHA; Sigma, St. Louis, MO) for 3 days.
ocultures were maintained in RPMI 1640 containing
L-glutamine (JRH Biosciences, Lenexa, KS), 10% fetal calf
erum (FCS) (CSL, Victoria, Australia), 10% IL-2 (Boeh-











523NEUROTROPISM OF HIV-1units/ml penicillin and 100 mg/ml streptomycin (Life
Technologies, NY). Cocultures were maintained for 28
days with weekly passaging on fresh PHA-stimulated
donor PBMCs. Thereafter, the cocultures were termi-
nated, the cells were harvested, and the supernatant
was tested for reverse transcriptase activity as previ-
ously described (Wang et al., 1996). The PBMC cell pel-
lets were lysed in 100 ml lysis buffer for 10 min (50 mM
Cl, 10 mM Tris–HCl, pH 8.3, 2.5 mM MgCl2, 0.01%
elatin, 0.45% NP-40, and 0.45% Tween-20) collected in
ppendorff tubes, and 5 ml Proteinase K (20 mg/ml)
(Boehringer-Mannheim) was added. Samples were then
incubated at 60°C for 2 h, and the Proteinase K was
inhibited by incubation at 95°C for 10 min. The DNA-
containing lysates were stored at 220°C.
Tropism of brain-derived HIV-1 isolates
on primary cells
Monocytes, MDMs, and T-lymphocytes were prepared
from 400 ml whole blood from each of three additional
HIV-negative donors (A, B, and C). PBMCs were sepa-
rated by centrifugation of the whole blood on a Ficoll-
Hypaque (Pharmacia-AMRAD) gradient. Monocytes
were isolated from the PBMCs by countercurrent elutria-
tion using a J-6M/E Beckman centrifuge and a JE-5.0
elutriation rotor with a 4-ml elutriation chamber (Beck-
man Instruments). T cells contaminating the monocyte
fractions were depleted by complement-dependent cyto-
toxicity using anti-CD3 antibody (OKT3; Ortho-Diagnos-
tics) and lysis with baby rabbit complement. Morpholog-
ical examination established purity of the monocyte pop-
ulation. The 48-well tissue culture plates were seeded in
duplicate with 1.8 3 106 monocytic cells/ml in RF 10/10
edium (RPMI 1640 with L-glutamine, 100 units/ml pen-
icillin, 100 mg/ml streptomycin, 10% pooled human AB
serum, and 10% FCS). Within 18 h, the medium was
removed from each of the wells of the one monocyte
plate and infected for 6 h with a total of 100,000 cpm/ml
(as determined by RT assay) of stock virus supernatant
derived from each of the brain tissues expanded by
coculture on PBMCs. Thereafter, all wells were washed
three times with prewarmed PBS, and finally 1 ml of RF
10/10 was added. The plates were maintained for 21
days, and half of the medium was exchanged twice
weekly. The second plate seeded with monocytes was
allowed to differentiate into MDMs, and on day 5, the
plates were infected with the viral supernatants, as was
done for the first monocyte plate. The pooled T-cell frac-
tions were placed in a flask with RPMI 1640 supple-
mented with L-glutamine, 10% FCS, 100 units/ml penicil-
in, 100 mg/ml streptomycin, and 10% PHA and incubated
or 3–5 days. The T-lymphocytes were spun down on day
and seeded onto 5-ml tissue culture tubes at 1 3 106cells/ml. After the cells had settled, a minimal amount of
medium was left in the wells, and then they were in-fected with the viral supernatant as previously. After 6 h
of incubation, the cells were washed three times with
prewarmed PBS and low-speed (500 3 g) centrifugation.
The final pellet was resuspended in 1 ml RPMI 1640
supplemented with L-glutamine, 10% FCS, 100 units/ml
penicillin, 100 mg/ml streptomycin, and 10% IL-2. The
T-cell cultures were also maintained for 21 days with
twice-weekly exchanges of half of the medium. Mono-
cytes, MDMs, and T cells were also infected with 100
cpm/ml viral supernatant from PBMC cultures infected
with HIV-BaL and HIV-pNL4-3, and at least two unin-
fected wells or tubes were maintained as negative con-
trols. Culture supernatants were examined for HIV-1 p24
antigen (Coulter HIV-1 p24 Antigen Assay) and regarded
as positive if values exceeded the assay cutoff value.
The monocytes, MDMs, and T cells were then lysed on
termination of the cultures, and DNA was extracted as
previously done for the PBMC cell pellets.
Determination of coreceptor use on HOS cells
expressing CD4 and various chemokine receptors
Stably transfected HOS cells expressing a functional
human CD4 gene, as well as one of the chemokine
receptors, were used to investigate the specific corecep-
tor use of the expanded brain-derived isolates from
patients ND, LD, and ED. HOS-CD4, HOS-CD4-CCR1,
HOS-CD4-CCR2b, HOS-CD4-CCR3, HOS-CD4-CCR4,
HOS-CD4-CCR5, HOS-CD4-CXCR4, HOS-CD4-BOB, and
HOS-CD4-BONZO (kindly provided by Dr. Daniel Littman,
New York University Medical Center, New York, NY) were
maintained in DMEM (JRH Biosciences, Lenexa, KS) with
10% FCS, 100 units/ml penicillin, 100 mg/ml streptomycin,
1 mg/ml puromycin (Sigma), 100 mg/ml Hygromycin B
(Sigma), and 500 mg/ml geneticin (G418) (Life Technolo-
ies). The medium for the parental HOS-CD4 cells did
ot contain puromycin (Sigma). The HOS cells were
lated at 1 3 106 cells/well in 24-well plates and, when
85% confluent, were infected with 40,000 cpm/ml of viral
stock overnight. All cultures were then washed three
times with 2 ml of prewarmed PBS. The different core-
ceptor expressing HOS cells were also infected with
40,000 cpm/ml of viral supernatant from PBMC cultures
infected with HIV-BaL and HIV-pNL4-3, and at least two
uninfected wells were maintained as negative controls.
The cultures were maintained in 2 ml of DMEM de-
scribed earlier. Supernatants (1 ml) were collected from
the cultures every 3–4 days. Infection was determined by
p24 antigen ELISA on culture supernatants at day 14 and
PCR amplification of the env region from DNA extracted
from the cell lysates on termination of the cultures at day
18.
Syncytium formationSyncytium formation by viral isolates was determined





















524 SMIT ET AL.cocultured with 2 3 106 MT-2 cells in 4 ml RPMI 1640
with L-glutamine, 100 units/ml penicillin, and 100 mg/ml
streptomycin supplemented with 10% FCS. The cultures
were checked twice weekly for the presence of multinu-
cleated giant cells, and the medium was replenished
every 3–4 days.
PCR amplification of the env C2-V5 region
Frozen tissue samples (60.3 cm3) from the LF, RF, LP,
RP, LO, and RO regions of patients ND (except the LO
region) and LD were disrupted in liquid nitrogen, and
DNA was extracted with the QIAamp Tissue Kit accord-
ing to the manufacturer’s protocol (Qiagen, Chatsworth,
CA).
All DNA extracts obtained directly from the brain tis-
sues, cultured PBMCs, primary cells (monocytes, MDMs,
and T cells), and HOS-CD4-CCR5-infected cells were
used to amplify the C2-to-V5 region of the env gp120 by
a nested PCR. Genomic DNA (1 mg) was used in the first
ound of the reaction with primers ED5 and ED12 (Del-
art et al., 1995) in a final volume of 50 ml. The first round
eaction was performed with an initial denaturation at
5°C for 5 min followed by 35 cycles consisting of de-
aturation at 95°C for 30 s, annealing at 55°C for 30 s,
nd elongation at 72°C for 2 min 30 s. For the second
ound of PCR amplification, 10 ml of the first round reac-
tion was used as template, with primers ES7 and ES8
(Delwart et al., 1995) in a final volume of 100 ml, using the
ame cycling conditions as used for the first round re-
ction. Primers ES7 and ES8 amplified a 0.7-kb fragment
ncompassing the C2-to-V5 region of the env gp120. The
CR products were run on a 1% agarose gel (Promega,
adison, WI) in TBE buffer and visualized under UV light.
loning
The C2-to-V5 env gene PCR fragments from proviral
NA from the PBMCs infected with the brain-derived
solates were cloned into the pGEM-T vector (pGEM-T
asy Vector System II; Promega) according to the man-
facturer’s instructions. The clones were screened for
he env gene insert by performing a quick lysis of the
acteria at 95°C for 5 min and then using 5 ml directly in
a 25-cycle PCR with the internal primer pairs (ES7 and
ES8). Positive clones were grown in Luria’s broth with
ampicillin overnight at 37°C. The plasmid DNA from
positive clones was extracted as previously described
(Wang et al., 1996), and the clones were sequenced on
an ABI automated sequencer.
Sequencing and phylogenetic analyses
of the env region
The C2-to-V5 region sequences derived from different
regions of brain and each of the infected cell types were
aligned using CLUSTAL-W (Thompson et al., 1994) from
the GCG package, with default settings, and improvedmanually. The V3 loop charge calculations were derived
from the peptide sequence of the 35-amino acid V3 loop
regions using DNA ID 1.8 (Frederick Dardel, Paris,
France). This program assigns 11 charge to basic amino
acid residues, 21 charge to acidic residues, and 0 to the
remaining residues. The pairwise nucleotide distances
were calculated by the Kimura two-parameter model in
PHYLIP (Kimura, 1980). The phylogenetic trees were con-
structed by the neighbor joining method integrated in the
PHYLIP package (Felsenstein, 1989), and the trees were
bootstrapped with 100 replications to generate phyloge-
netically significant relationships between variants from
different brain regions using SEQBOOT.
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